[Study of three kinds of primary immunization schedules with poliovirus vaccine]

J M Zhang1, X M Xu1, Y F Wang1

  • 1Institute of Immunization Program Management, Hebei Provincial Center for Disease Control and Prevention,Shijiazhuang 050021, China.

Insights

Comparing poliovirus vaccine schedules, this study found all three regimens induced high antibody levels in infants. The 2sIPV+1bOPP and 3sIPV schedules showed better immunogenicity against type II poliovirus than 1sIPV+2bOPV.

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Poliovirus remains a global health concern, necessitating effective vaccination strategies.
  • Understanding the immunogenicity of different poliovirus vaccine schedules is crucial for optimizing public health interventions.

Purpose of the Study:

  • To compare the immunogenicity of three distinct poliovirus vaccine immunization programs in infants.
  • To evaluate the development of poliovirus neutralizing antibodies following different vaccination schedules.

Main Methods:

  • Healthy infants were randomized into three groups receiving different combinations of inactivated poliovirus vaccine (sIPV) and bivalent oral poliovirus vaccine (bOPV).
  • Serum samples were collected before and 28-42 days after basic immunization.
  • Polio neutralizing antibody levels were measured using the microcell neutralization method and analyzed statistically.

Main Results:

  • All three immunization programs achieved high positive conversion rates (>97%) and positive rates (>98%) for poliovirus types I, II, and III antibodies.
  • Significant increases in geometric mean titers (GMT) of neutralizing antibodies were observed in all groups post-immunization (P<0.05).
  • The 2sIPV+1bOPV and 3sIPV groups demonstrated superior GMT for type II poliovirus compared to the 1sIPV+2bOPV group.

Conclusions:

  • All evaluated poliovirus vaccine schedules effectively induce high levels of neutralizing antibodies, forming a strong immune barrier against poliovirus.
  • While all schedules showed good immunogenicity, specific differences were noted, with 2sIPV+1bOPV and 3sIPV offering better protection against type II poliovirus.